Standards and Medical Device Regulation Roundtable. Seoul South Korea. 21 October ASTM International

Similar documents
CDRH Standards Program

Requests for Feedback and Meetings for Medical Device Submissions: The Q-Submission

Guidance for Industry and Food and Drug Administration Staff

Interactive Review for Medical Device Submissions: 510(k)s, Original PMAs, PMA Supplements, Original BLAs, and BLA Supplements

World Accreditation Day Webinar

DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Document issued on: August 5, 2008

*Applicable to: Beaumont Health. Document Type: Policy

Received an RTA Deficiency List or AI Letter? Now What?

Guidance for Industry and FDA Staff Radiation Safety Considerations for X-Ray Equipment Designed for Hand-Held Use

Document issued on: July 8, 2010

Guidance for Industry ANDA Submissions Prior Approval Supplements Under GDUFA

Changes to QSR. The table below provides a history of changes to FDA s Quality System Regulation (QSR)

Inspections, Compliance, Enforcement, and Criminal Investigations

Pre-Submissions and Meetings with FDA Staff

PLAN OF ACTION FOR IMPLEMENTATION OF 510(K) AND SCIENCE RECOMMENDATIONS

MDUFA Performance Goals and Procedures Process Improvements Pre-Submissions Submission Acceptance Criteria Interactive Review

AN OVERVIEW OF CLINICAL STUDY TASKS AND ACTIVITIES

Establishment Registration and Device Listing. Michelle C. Jackson, Esq. Partner Venable LLP

FDA Guidance Hot Topics: Pre-Submission Guidance Review AMDM Focus Meeting October 25, Elizabeth Hillebrenner, MSE OIR/CDRH/FDA

Organizations in Nuclear Medicine Part IV- Others of Importance. Bennett S. Greenspan, MD SNM MWM Orlando, FL January 27, 2012

FDA Outlook Seth A. Mailhot, Partner Lead, FDA Regulatory Practice

Review of Existing Center for Drug Evaluation and Research Regulatory and Information

November 7, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852

Latham & Watkins Corporate Department

Medical Device Reporting for Manufacturers

FDA s Office of Regulatory Affairs: Violation Trends & Medical Device Update

WARNING LETTER CERTIFIED MAIL -~ Q December 14, 2005

Introduction to Coverage Analysis Part 1. Amanda Miller, Training Program Manager Derek McCormick, Operations Manager October 14, 2016

Medical Devices and Device-Led Combination Products; Voluntary Malfunction Summary

FDA Perspective on the Pre- Submission Program: Updates from MDUFA IV

Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors. Exception from Informed Consent Requirements for Emergency Research

AAPM Responds to Follow up Questions from Congress after Hearing on Radiation in Medicine

Department of Defense INSTRUCTION

I. Preamble: II. Parties:

GAO MEDICAL DEVICES. Status of FDA s Program for Inspections by Accredited Organizations. Report to Congressional Committees

WARNING LETTER. an both of which were sponsored by. (formerly ). The products

Center for Devices and Radiological Health; Medical Devices and Combination Products;

Establishment of the FDA Office of Patient Affairs

The FDA Medical Device User Fee Program: MDUFA IV Reauthorization

Registry of Patient Registries (RoPR) Policies and Procedures

CENTRAL SERVICE (CS) TECHNICIANS PERFORM MANY IMPORTANT

The FDA Medical Device User Fee Program

May 12, 2016 MEMORANDUM. Certain provisions of FSMA are already in effect, namely: Mandatory recall authority (FSMA 206).

Pediatric Medical Devices: The FDA Postmarket Perspective

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service 3%3&4

DEPARTMENT OF VETERANS AFFAIRS Presumption of Herbicide Exposure and Presumption of Disability During Service For

WikiLeaks Document Release

Technical Revisions to Update Reference to the Required Assessment Tool for. State Nursing Homes Receiving Per Diem Payments From VA

Regulatory Affairs Outsourcing

Case: 1:10-cv Document #: 74-1 Filed: 04/15/11 Page 1 of 7 PageID #:2403 EXHIBIT A

SPONSOR-INVESTIGATOR ROLES & RESPONSIBILITIES IN DEVICE TRIALS

Agency Information Collection Activities; Submission for Office of Management and Budget

Medicare Part C Medical Coverage Policy

ISO14155: 2011 Clinical investigation of medical devices for human subjects - Good Clinical Practice - ISO TC194 WG4 Madoka Murakami PMDA, Japan

Request for Proposals (RFP) to Provide Auditing Services

APPENDIX N FEDERAL AUDIT CLAUSES

ADMINISTRATIVE INSTRUCTION

May 8, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD

: study utilizing trieib)(4) b)(4) I I""-", _

NRC REGULATORY ISSUE SUMMARY RADIATION SAFETY OFFICERS FOR MEDICAL-USE LICENSES UNDER 10 CFR PART 35

AD-A , Department of Defense NUMBER SUBJECT:

DOE N /29/95 Expires: [1 year after initiation]

Pediatric Medical Device Development and Safety. Jacqueline N. Francis, MD, MPH Medical Officer, PSRB, ODE, CDRH, FDA

DEPARTMENT OF VETERANS AFFAIRS Special Home Adaptation Grants for Members of the Armed Forces and Veterans with

DEPARTMENT OF VETERANS AFFAIRS SUMMARY: This document implements a portion of the Veterans Benefits,

A Competitiveness Policy for the Medical Technology Industry: Six Policy Proposals to Sustain American Leadership

Take a Course of Action.

AGENCY: Office of Postsecondary Education, Department of. SUMMARY: The Secretary adopts as final, without change, the

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service

Introduction of Saudi Arabia Medical Device Regulatory System Ali Al Dalaan Executive Director, SFDA AHWP TC Chair

Request to Use an External IRB as an IRB of Record

South Carolina Trade Mission to South Korea and Japan September 5-11, 2018

Cannabis Licensing. alberta.ca/cannabis. aglc.ca/cannabis

WARNING LETTER VIA FEDERAL EXPRES S

NIJ 2005 Interim Requirements for Bullet-Resistant Body Armor

4.12 Effort Certification

Version 1.1, 6/30/2016 Guidance for Abbreviated IDE Requirements

4.2. Clinical Trial Monitor (or Monitor): The person responsible for monitoring the data on behalf of the sponsor or contract research organization.

(Revised January 15, 2009) DISCLOSURE OF INFORMATION (DEC 1991)

Update on Premarket Notification Requirements Concerning Gowns Intended for Use in Health Care

GRANTS AND CONTRACTS (FINANCIAL GRANTS MANAGEMENT)

Software Regulation and Validation

The FDA Food Safety Modernization Act of 2009 Section-by-Section Summary

Office of Surface Mining Reclamation and Enforcement

COMPLIANCE WITH THIS PUBLICATION IS MANDATORY

General Administration GA STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility

CIRSE Fellowship Information and Application

Real-World Evidence: A CDRH Perspective

STATEMENT. JEFFREY SHUREN, M.D., J.D. Director, Center for Devices and Radiological Health Food and Drug Administration

eirb Review Checklist

DEPARTMENT OF HEALTH & Hl'NIAfV SERVICES Public Hcaffh Scn-ice WARNING LETTER

. s%rwcu ~,+ *+ % %vd3a 7 Food and Drug Administration. Center for Devices and

2015 Annual FDA Medical Device Quality System Data. Inspections, FDA Form 483 Observations, and Warning Letter Citations

COUNTY OFFICIAL PLAN AMENDMENT PROCESS (TYPICAL)

Accelerated Translational Incubator Pilot (ATIP) Program. Frequently Asked Questions. ICTR Research Navigators January 19, 2017 Version 7.

DRAFT REGULATORY GUIDE

Modernizing Hospital Adverse Event Reporting

FINANCIAL AUDITING SERVICES. July 10, :00 PM

Record or Document Type Retention Period Relevant Legal Citation(s) IRB Records: Training Records;

FDA Inspectional Process in Clinical Research An FDA Perspective. Annette Melendez, MPHsN Investigator Office of Biological Products Operations

Transcription:

Standards and Medical Device Regulation Roundtable Seoul South Korea 21 October 2014

FDA s Use of Voluntary Consensus Standards Scott Colburn, Director CDRH Standards Program Office of the Center Director, Center for Devices and Radiological Health Seoul, South Korea, 21 October 2014 www.astm.org

Today s Topics 1 Mission, Vision, Regulation 2 Why Are Standards Important? 3 Key Legislation and Goals 4 CDRH Standards Program 5 Agency s Use of Standards and Guidance

Section 1 Mission & Vision of CDRH

Mission & Vision of CDRH - The mission of the Center for Devices and Radiological Health (CDRH) is to: - Protect and promote the public health - Ensure patients have access to highquality, safe, and effective medical devices of public health importance first in the world

FDA Use of Regulation - FDA uses regulations and product standards as the yardsticks to: - Define specific requirements manufacturers follow to assure product safety - Provide accurate information to health professionals and consumers - The medical device regulatory framework is based on RISK

Section 2 Why are Private Sector Standards Important?

Private Sector Standards Are Important - Gives agencies discretion to use standards (other than FDA standards) - Builds consistency, credibility, and predictability - Integral in the execution of the FDA mission - Greater potential to save time and money rather than FDA development of technical standards - Open participation by affected parties - Minimizes or eliminates inconsistent standards internationally - Can lead to international harmonization on issues - Often represents leading-edge thinking on an issue

Section 3 Legislative Goals

Legislative Goals - Eliminate unnecessary government costs - Provide incentives that serve national and global market needs - Encourage long-term growth for the US - Promote economic competition

National Technology Transfer and Advancement Act of 1995 (NTTAA) Directs Federal Agencies to: - Adopt private sector standards in lieu of creating proprietary, non-consensus standards - Participate in voluntary consensus standards bodies

OMB Circular A-119 Sets forth requirements for: - Agency participation - Annual reporting - Incorporation by reference of standards into regulation

CDRH Standards Program Medical Device Amendments of 1976 - USC 514 Safe Medical Device Act of 1990 - Promulgation of mandatory standards at the Agency s discretion FDA Modernization Act of 1997 - Revised 514c - Added ability to formally recognize a standard, all or in part - Added ability to accept a formal Declaration of Conformity

Standards Management Program Created by Food and Drug Administration Modernization Act (FDAMA) of 1997. The Standards Program - Is a regulatory support activity consisting of cross-office teams - Works closely with the Standards Developing Organizations (SDOs) - Advertises standards liaison representative positions - Facilitates Center recommendations on particular standards - Maintains standards databases - Provides all CDRH staff access to established standards - Updates currently recognized standards, coordinates recognition of new national and international voluntary consensus standards for - Medical devices - Radiation-emitting electronic products

FDA/CDRH Standards Program - 17 Specialty Task Groups (STGs) covering 23 different scientific/device areas - Participate in ~590* national and international committees - 370 staff participating in standards development - 1050 currently recognized standards - Conduct two to four recognition cycles per year * Typically see a 5-10% increase in requests for new standards development activities each year

CDRH Standard Operating Procedures - Identification and Evaluation of Candidate Consensus Standards for Recognition - Typically two to three times per year (Spring and Fall), incorporates several steps - Initiation - Screening - Scientific discussion - Loop - Supplemental information sheet preparation and technical contact identification - Recognition of paperwork

Standards Utilization & Guidance CDRH believes that: - Conformance with recognized consensus standards can support a reasonable assurance of safety and/or effectiveness - Such standards should have a direct bearing on safety and effectiveness determinations made for - Investigational Device Exemptions (IDE) - Humanitarian Device Exemptions (HDE) - Premarket Approvals (PMA) - Product Development Protocols (PDP)

Standards Utilization & Guidance - The use of consensus standards generally satisfies only one part of a premarket submission - It usually does not satisfy all the required elements of a submission - It may not, on its own, provide sufficient basis for a regulatory decision - FDA recognition of a standard does not supersede other aspects of the FD&C Act - Nor its implementation, regulations for marketing, or investigation of medical devices in the US.

Premarket Utilization - Consensus standards are very useful when a recognized standard, that serves as a complete performance standard for a specific medical device, exists - Comprehensive consensus standards are rare - Conformance with a particular recognized consensus standards may not always be a sufficient basis for regulatory decisions

Contact information: - CDR Scott Colburn Director, CDRH Standards Program Office of the Center Director Center for Devices and Radiological Health Food and Drug Administration 301-796-6287 scott.colburn@fda.hhs.gov

Thank you www.astm.org